Table 7.
Item | Treatments 1 | SEM 2 | p Value 3 | |||
---|---|---|---|---|---|---|
0 | 75 | 100 | C1 | C2 | ||
Ʃ 10-C a 14-C 4 | 3.10 | 3.14 | 3.12 | 0.022 | 0.530 | 0.716 |
Ʃ acima de 16-C 5 | 97.62 | 97.63 | 97.64 | 0.024 | 0.985 | 0.948 |
Ʃ AGS 6 | 43.50 | 43.55 | 43.49 | 0.047 | 0.874 | 0.602 |
Ʃ AGI 7 | 57.22 | 57.23 | 57.26 | 0.048 | 0.879 | 0.755 |
Ʃ AGMI 8 | 51.35 | 51.42 | 51.40 | 0.061 | 0.682 | 0.939 |
Ʃ AGPI 9 | 5.86 | 5.80 | 5.85 | 0.034 | 0.601 | 0.572 |
Ʃ AGCI 10 | 2.30 | 2.32 | 2.30 | 0.013 | 0.735 | 0.520 |
Ʃ AG ω311 | 0.362 | 0.360 | 0.363 | 0.002 | 0.935 | 0.675 |
Ʃ AG ω6 12 | 4.96 | 4.90 | 4.94 | 0.003 | 0.627 | 0.607 |
Ratio sat/insat 13 | 1.31 | 1.32 | 1.32 | 0.001 | 0.932 | 0.658 |
Ratio sat/insat 18-C 14 | 0.336 | 0.334 | 0.335 | 0.110 | 0.514 | 0.706 |
Ratio ω6: ω3 15 | 13.73 | 13.64 | 13.63 | 0.022 | 0.703 | 0.991 |
Product/substrate relationship 16 | ||||||
C:14:1/14:0 | 6.73 | 6.63 | 6.37 | 0.102 | 0.280 | 0.301 |
C:16:1/16:0 | 13.32 | 13.16 | 12.86 | 0.095 | 0.136 | 0.196 |
C: 18:1/18:0 | 0.363 | 0.362 | 0.363 | 0.001 | 0.867 | 0.772 |
Δ 9 desaturase C16:0 | 6.99 | 7.06 | 7.21 | 0.047 | 0.125 | 0.196 |
Δ 9 desaturase C18:0 | 73.36 | 73.39 | 73.33 | 0.062 | 0.982 | 0.728 |
Elongase | 73.75 | 73.64 | 73.68 | 0.045 | 0.398 | 0.755 |
Atherogenic index | 0.676 | 0.644 | 0.601 | 0.006 | 0.077 | 0.239 |
Thrombogenic index | 0.966 | 0.972 | 0.970 | 0.002 | 0.416 | 0.777 |
Index h:H 17 | 2.247 | 2.233 | 2.2440 | 0.005 | 0.451 | 0.399 |
1 Inclusion of BOVAER® (3-nitrooxypropanol, mg/kg DM). 2 SEM (standard error of the mean). 3 C1 (control vs. BOVAER®); C2 (75 vs. 100 mg/kg MS BOVAER®). 4 Fatty acids from 4 to 14 carbons; 5 Fatty acids with more than 16 carbons; 6 Saturated fatty acids; 7 Unsaturated fatty acids; 8 Monounsaturated fatty acids; 9 Polyunsaturated fatty acids; 10 Odd-chain fatty acids; 11 Omega 3 fatty acids; 12 Omega 6 fatty acids; 13 Total saturated/unsaturated fatty acids ratio; 14 Relationship of saturated/unsaturated fatty acids with 18 carbons; 15 Relationship of omega 6: omega 3 fatty acids; 16 Product/substrate relationship of the enzyme stearoyl-CoA desaturase; 17 Relationship of hypocholesterolemic and hypercholesterolemic fatty acids.